Rahul Mannan

Rahul Mannan

University of Michigan

H-index: 20

North America-United States

About Rahul Mannan

Rahul Mannan, With an exceptional h-index of 20 and a recent h-index of 19 (since 2020), a distinguished researcher at University of Michigan, specializes in the field of Histopathology, Molecular pathology, GU Pathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Suggested searches

Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS)

Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients—A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations …

Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

Abstract A034: Development of a novel class of genomic biomarkers through mathematical modeling of cancer genome contiguity

Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer

p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer

Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma

Rahul Mannan Information

University

Position

Research Fellow MCTP Pathology

Citations(all)

1974

Citations(since 2020)

1646

Cited By

614

hIndex(all)

20

hIndex(since 2020)

19

i10Index(all)

36

i10Index(since 2020)

26

Email

University Profile Page

Google Scholar

Rahul Mannan Skills & Research Interests

Histopathology

Molecular pathology

GU Pathology

Top articles of Rahul Mannan

Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS)

Medical Oncology

2024/3

Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients—A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations …

The American journal of surgical pathology

2024/2/1

Abstract A034: Development of a novel class of genomic biomarkers through mathematical modeling of cancer genome contiguity

Cancer Research

2024/1/9

Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer

Proceedings of the National Academy of Sciences

2024/4/9

Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma

Neoplasia

2024/1/6

Genome instability in renal tumors

Cancer Research

2024/3/22

Deletion of the lipid kinase PIKfyve in Kras-driven pancreatic genetically engineered mouse model

Cancer Research

2024/3/22

Pan-tissue master regulator inference reveals mechanisms of MHC alterations in cancers

Cancer Research

2024/3/22

Targeting AR positive prostate cancer cells by the novel P300/CBP oral available PROTAC degrader

Cancer Research

2024/3/22

Harnessing PIKfyve as a therapeutic vulnerability in neuroendocrine prostate cancer

Cancer Research

2024/3/22

Targeting the SWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies

Cancer Research

2024/3/22

Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies

bioRxiv

2024

FOXA1 alterations distinctively drive prostate tumorigenesis or therapy resistance in mice

Cancer Research

2024/3/22

Targeting lipid metabolism in pancreatic cancer

Cancer Research

2024/3/22

See List of Professors in Rahul Mannan University(University of Michigan)

Co-Authors

academic-engine